Sphincter preservation of leiomyosarcoma of the rectum and anus with local excision and brachytherapy

Dis Colon Rectum. 1999 Oct;42(10):1296-9. doi: 10.1007/BF02234218.

Abstract

Purpose: The aim of this study was to determine the outcome of patients with leiomyosarcoma of the rectum or anus treated with local excision and brachytherapy.

Methods: Eight patients with leiomyosarcoma of the rectum (7 patients) or anus (1 patient) were treated with a transanal excision followed by a temporary iridium-192 interstitial implant to 4,500 cGy. Median tumor size was 4.2 (range, 1.5-5) cm. Margins were positive in six patients, negative in one patient, and close in one patient.

Results: With a median follow-up of 53 months, median survival time was 53 months and the three-year actuarial survival rate was 71 percent. The cumulative incidence of failure as a component of failure for local was 25 percent (2/8), for abdominal was 0 percent (0/8), and for distant was 25 percent (2/8). Four patients eligible for functional analysis all had excellent sphincter function (1-2 bowel movements per day, no soilage).

Conclusion: In selected patients the use of conservative surgery followed by brachytherapy is a reasonable alternative to an abdominoperineal resection. However, more experience and longer follow-up are needed before this approach can be recommended routinely.

MeSH terms

  • Anal Canal* / physiology
  • Anus Neoplasms / mortality
  • Anus Neoplasms / radiotherapy*
  • Anus Neoplasms / surgery*
  • Brachytherapy*
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Iridium Radioisotopes / therapeutic use*
  • Leiomyosarcoma / mortality
  • Leiomyosarcoma / radiotherapy*
  • Leiomyosarcoma / surgery*
  • Male
  • Middle Aged
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / radiotherapy*
  • Rectal Neoplasms / surgery*
  • Survival Rate
  • Time Factors
  • Treatment Failure

Substances

  • Iridium Radioisotopes